Tribenoside

This classification denotes a non-steroidal anti-inflammatory agent with the molecular formula C29H34O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z7N0Y673NU, chemically known as glucofuranoside, ethyl-3,5,6-tri-o-benzyl-, d- but generally known as tribenoside, which bears US NIH Compound Identifier 25145. European Medicines Agency schedules Tribenoside in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11260MIG. World Health Organization schedules tribenoside in its Anatomical Therapeutic Chemical (ATC) Classification. TRIBENOSIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tribenoside under HS 29400000 and SITC 51692. As of Q4 2014, TRIBENOSIDE remains the US FDA Preferred Term for this commodity. SMILES: O1C(C(OCC2CCCCC2)C(O)C1OCC)C(OCC1CCCCC1)COCC1CCCCC1.